Palo Alto, California-based Cognoa’s machine learning app for pediatric behavioral health has received categorization from the FDA as a Class 2 diagnostic medical device for autism, according to an announcement from the company.
New York and Palo Alto, California-based MemoryMD has received FDA clearance for NeuroEEG, a wireless amplifier that transmits EEG signals to computers and cloud-based databases via Bluetooth. The other half of MemoryMD's offering, a disposable EEG cap called NeuroCap, is still awaiting clearance.
Roche’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On February 15, the agency issued a Class 2 Device Recall for certain software versions of the app due to a bug that could lead users to self-administer inappropriate doses of insulin.
Optra Health, which produces AI-driven iPhronesis analysis platform for healthcare and life sciences clients, today announced the launch of a new genetics-focused product specially designed for consumers, genetic counselors, and other genomics researchers.
The University of Pennsylvania's Penn Medicine has been an active player in the telehealth game for sometime with multiple telehealth units, but last week it went a step further to announce that it will be centralizing its telemedicine activities into the Penn Medicine Center for Connected Care.
OrCam, an Israeli company working on augmented reality for the blind and vision impaired, has raised $30.4 million. According to Reuters, which broke the news, the round included Israeli insurer Clal Insurance and investment group Meitav Dash.
Researchers from Microsoft are aiming to transform the world of virtual reality from a primarily visual experience to a tactile and auditory one for people with visual impairments.
With so many innovative ideas circulating, conference attendees are hard-pressed to cover all of it. To help provide more knowledge in a shorter time span, the Innovation Live exhibit area will be hosting a new format. Lightning Sessions are 20-minute presentations that will cover some of the most pressing issues in the industry from using analytics in the real world to dealing with interoperability in the EHR workflow.
Google AI has made a breakthrough: successfully predicting cardiovascular problems such as heart attacks and strokes simply from images of the retina, with no blood draws or other tests necessary.